De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

AcroMeta Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

AcroMeta Group heeft een totaal eigen vermogen van SGD1.7M en een totale schuld van SGD5.8M, wat de schuld-eigenvermogensverhouding op 346% brengt. De totale activa en totale passiva bedragen respectievelijk SGD31.8M en SGD30.1M.

Belangrijke informatie

346.0%

Verhouding schuld/eigen vermogen

S$5.81m

Schuld

Rente dekkingsratio	n/a
Contant	S$4.94m
Aandelen	S$1.68m
Totaal verplichtingen	S$30.14m
Totaal activa	S$31.82m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( SGD23.5M ) van 43F } dekken niet de korte termijn passiva ( SGD26.3M ).

Langlopende schulden: De kortetermijnactiva 43F ( SGD23.5M ) overtreffen de langetermijnschulden ( SGD3.8M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 51.7% ) 43F wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 43F is de afgelopen 5 jaar gestegen van 42.4% naar 346%.

Schuldendekking: De operationele kasstroom van 43F is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van 43F op haar schulden goed worden gedekt door EBIT.

AcroMeta Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Anton Setiawan acquired 67% stake in PT Acromec Trading Indonesia from AcroMeta Group Limited (Catalist:43F) for SGD 5000.

Executive Director recently bought S$53k worth of stock

High number of new and inexperienced directors

Acrometa Group Limited Appoints Toh Ker How as the Executive Director of the Company

An undisclosed buyer agreed to acquire 70% stake in Life Science Incubator Pte Ltd from AcroMeta Group Limited (Catalist:43F).

First half 2024 earnings released: S$0.007 loss per share (vs S$0.004 profit in 1H 2023)

AcroMeta Group Limited Announces Re-Designation of Lim Say Chin as Executive Director to Executive Chairman

Acrometa Group Limited Announces Resignation of Levin Lee Keng Weng as Executive Chairman

High number of new and inexperienced directors

AcroMeta Group Limited Announces Retirement of Chew Chee Keong as Executive Director, Effective 30 January 2024

Full year 2023 earnings released: EPS: S$0.036 (vs S$0.028 in FY 2022)

AcroMeta Group Limited, Annual General Meeting, Jan 30, 2024

Full year 2023 earnings released: EPS: S$0.033 (vs S$0.012 in FY 2022)

New minor risk - Financial data availability

AcroMeta Group Limited has filed a Follow-on Equity Offering in the amount of SGD 0.5 million.

AcroMeta Group Limited has filed a Follow-on Equity Offering in the amount of SGD 0.5 million.

Acrometa Group Limited Appoints Cheah Lai Min as Chief Financial Officer

New minor risk - Share price stability

Acrometa Group Limited Announces Resignation of Tan Buck Kiang Jerry as Chief Financial Officer

AcroMeta Group Limited (Catalist:43F) completed the acquisition of additional 40% stake in Life Science Incubator Pte Ltd.

First half 2023 earnings released: EPS: S$0.004 (vs S$0.001 in 1H 2022)

Executive Chairman recently sold S$126k worth of stock

AcroMeta Group Limited (Catalist:43F) entered into a legally binding letter of intent to acquire additional 40% stake in Life Science Incubator Pte Ltd for SGD 1.6 million.

Acrometa Group Limited Appoints Cheong Keng Chuan, Alfred as Non-Executive and Lead Independent Director, Audit Committee Chairman and Member of the Nominating Committee and Remuneration Committee

Non-Executive Non-Independent Director recently sold S$56k worth of stock

Less than half of directors are independent

AcroMeta Group Limited Appoints Levin Lee Keng Weng as Executive Chairman and Director of the Board

AcroMeta Group Limited, Annual General Meeting, Jan 30, 2023

Acrometa Group Limited Announces Appointment of Mahtani Bhagwandas an Independent Director

Full year 2022 earnings released: EPS: S$0.012 (vs S$0.001 in FY 2021)

AcroMeta Group Limited Group Limited Announces Resignation of Elaine Beh Pur-Lin as Independent Director

Full year 2021 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Acromec Limited Appoints John Geno-Oehlers as Independent Director, Member of the Audit, Remuneration and Nominating Committees

Acromec Limited Announces Expiry of Memorandum of Understanding

Full year 2020 earnings released: S$0.011 loss per share

Acromec Limited, Annual General Meeting, Jan 27, 2021

Acromec Limited to Report Fiscal Year 2020 Results on Nov 27, 2020

Acromec Limited (Catalist:43F) completed the acquisition of remaining 40% stake in Golden Harvest Engineering Pte Ltd from Liang Kum Keong and Quek Ghee Leong.

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven